Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

GRAViceptive NEGlect Treatment in Acute Stroke Using Targeted Cranial ELECTrotherapy

NCT: NCT06747676 · SUSPENDED

NCT IDNCT06747676
StatusSUSPENDED
Start Date2025-01-03
Completion2028-01-15
SponsorUniversity of Sao Paulo (OTHER)
First posted
Last updated

Brief Summary

We aim to determine if targeted high-definition transcranial direct current stimulation (HD-tDCS) can safely correct errors in visual verticality perception in patients after stroke affecting either hemisphere.

Frequently Asked Questions

What is GRAViceptive NEGlect Treatment in Acute Stroke Using Targeted Cranial ELECTrotherapy?

GRAViceptive NEGlect Treatment in Acute Stroke Using Targeted Cranial ELECTrotherapy is a clinical trial registered under NCT06747676. Current status: SUSPENDED.

What is the status of NCT06747676?

The current status of NCT06747676 (GRAViceptive NEGlect Treatment in Acute Stroke Using Targeted Cranial ELECTrotherapy) is: SUSPENDED.

When did GRAViceptive NEGlect Treatment in Acute Stroke Using Targeted Cranial ELECTrotherapy start?

GRAViceptive NEGlect Treatment in Acute Stroke Using Targeted Cranial ELECTrotherapy started on 2025-01-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑